Pregled bibliografske jedinice broj: 910682
The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia
The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia // PeerJ, 4 (2016) doi:10.7717/peerj.2576 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 910682 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia
Autori
Bogdanović, Zoran ; Marinović-Terzić, Ivana ; Kuret, Sendi ; Jerončić, Ana ; Bradarić, Nikola ; Forempoher, Gea ; Polašek, Ozren ; Anđelinović, Šimun ; Terzić, Janoš
Izvornik
PeerJ (2167-8359) 4
(2016);
E2576, 0
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Genetic variation ; Hepatitis C ; IL-28 ; IL-6 ; Intravenous drug users ; Sustained virological response
Sažetak
Several genes and their single nucleotide polymorphisms (SNPs) are associated with either spontaneous resolution of hepatitis C infection or better treatment-induced viral clearance. We tested a cohort of intravenous drug users (IVDU) diagnosed with chronic hepatitis C virus (HCV) for treatment response and its association with the SNPs in the interleukin-6 (rs1800795-IL6) and the interleukin-28B (rs12979860-IL28B) genes. The study included 110 Croatian IVDU positive for anti-HCV antibody. Genotyping was performed by polymerase chain reaction (PCR) based approach. Patients were treated by standard pegylated- interferon/ribavirin and followed throughout a period of four years, during which sustained virological response (SVR) was determined. All data were analysed with statistical package SPSS 19.0 (IBM Corp, Armonk, NY, USA) and PLINK v1.07 software. Patients showed a significantly better response to treatment according to the number of copies of the C allele carried at rs1800795-IL6 (P = 0.034). All but one of the patients with CC genotype achieved SVR (93%), whereas the response rate of patients with GG genotype was 64%. The association of rs1800795-IL6 with SVR status remained significant after further adjustment for patients' age, fibrosis staging, and viral genotype (OR 2.15, 95% CI 1.16-4.68, P = 0.019). Distributions of allele frequencies at the locus rs12979860-IL28B among the study cohort and the underlying general population were suggestive of a protective effect of CC genotype in acquiring chronic hepatitis C in the Croatian IVDU population. The rs1800795-IL6 polymorphism is associated with positive response to treatment in IVDU patients positive for HCV infection. A protective role of rs12979860-IL28B CC genotype in acquiring chronic hepatitis C is suggested for Croatian IVDU population.
Izvorni jezik
Hrvatski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
Napomena
Dijeljena prva autorstva: Bogdanović, Zoran ; Marinović-Terzić, Ivana ; Kuret, Sendi ; Jerončić, Ana.
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-1904 - Uloga upale u razvoju zloćudnog tumora mokraćnog mjehura (iBC) (Terzić, Janoš, HRZZ ) ( CroRIS)
216-0000000-3348 - ULOGA UPALNIH PROCESA U NASTANKU MALIGNIH TUMORA (Terzić, Janoš, MZOS ) ( CroRIS)
258-2160800-0333 - DNA analiza ranosrednjovjekovne populacije s područja južne Hrvatske (Anđelinović, Šimun, MZOS ) ( CroRIS)
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Sveučilište u Splitu
Profili:
Nikola Bradarić
(autor)
Ivana Marinović Terzić
(autor)
Ozren Polašek
(autor)
Ana Jerončić
(autor)
Janoš Terzić
(autor)
Šimun Anđelinović
(autor)
Sendi Kuret
(autor)
Gea Forempoher
(autor)
Zoran Bogdanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus